Really?
It's all about the disruptive nature of the products and the fact that there are no realistic competitors in either the respiratory and sleep apnea marketplaces. Ping An do over 600,000 consultations a day, with respiratory ailments accounting for roughly 30-40%.
But I suspect you know all about this already, otherwise you wouldn't ask such a naive question.
- Forums
- ASX - By Stock
- RAP
- Revenue
Revenue, page-3
-
- There are more pages in this discussion • 111 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online